Clinical Trial Update: Characterization of Type 1 Diabetes Subgroup: An Artificial Intelligence Analysis of Clinical and Glucometric Features

View source ↗

Summary

A clinical trial is evaluating subgroups within Type 1 Diabetes Mellitus using artificial intelligence to analyze clinical and glucometric data.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Type 1 Diabetes Mellitus

Snippet

Sponsor: Fundació Institut de Recerca de l'Hospital de la Santa Creu i Sant Pau | Conditions: Type 1 Diabetes Mellitus | Status: RECRUITING